Enhabit, Inc. (NYSE:EHAB) Receives Average Recommendation of "Hold" From Brokerages
Enhabit, Inc. (NYSE:EHAB) Receives Average Recommendation of "Hold" From Brokerages
Enhabit, Inc. (NYSE:EHAB – Get Rating) has received a consensus recommendation of "Hold" from the eight brokerages that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $16.43.
据MarketBeat.com报道，EnHabit，Inc.(纽约证券交易所代码：EHAB-GET Rating)已收到覆盖该公司的八家经纪公司一致建议的“持有”。两名股票研究分析师对该股给予了卖出建议，四名分析师给出了持有建议，两名分析师对该公司发出了买入建议。在过去一年追踪该股的分析师中，平均12个月的价格目标是16.43美元。
A number of equities research analysts recently weighed in on EHAB shares. Oppenheimer started coverage on shares of Enhabit in a research report on Thursday, October 13th. They issued a "market perform" rating for the company. Stifel Nicolaus initiated coverage on Enhabit in a report on Monday, December 5th. They issued a "buy" rating and a $17.00 target price for the company. UBS Group initiated coverage on Enhabit in a report on Thursday, December 8th. They issued a "sell" rating and a $12.00 target price for the company. CJS Securities initiated coverage on Enhabit in a report on Tuesday, December 13th. They issued a "market perform" rating and a $18.00 target price for the company. Finally, Credit Suisse Group reduced their target price on Enhabit from $19.00 to $15.00 and set a "neutral" rating for the company in a report on Friday, November 4th.
一些股票研究分析师最近加入了Ehab的股票。10月13日，星期四，奥本海默在一份研究报告中开始报道EnHabit的股票。他们对该公司进行了“市场表现”评级。Stifel Nicolaus在12月5日星期一的一份报告中发起了对EnHabit的报道。他们对该公司的评级为买入，目标价为17.00美元。瑞银集团在12月8日星期四的一份报告中发起了对EnHabit的报道。他们对该公司的评级为“卖出”，目标价为12美元。CJS证券在12月13日(星期二)的一份报告中启动了对EnHabit的报道。他们对该公司的评级为“市场表现”，目标价为18.00美元。最后，瑞士信贷集团在11月4日(星期五)的一份报告中将EnHabit的目标价从19.00美元下调至15.00美元，并将该公司的评级定为“中性”。
Enhabit Price Performance
居住性价比
Shares of NYSE:EHAB opened at $15.11 on Tuesday. Enhabit has a 52 week low of $11.65 and a 52 week high of $25.25. The company's 50 day moving average is $13.49 and its two-hundred day moving average is $14.45. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.50 and a quick ratio of 1.50.
纽约证券交易所：Ehab的股票周二开盘报15.11美元。EnHabit的52周低点为11.65美元，52周高点为25.25美元。该公司的50日移动均线切入位在13.49美元，200日移动均线切入位在14.45美元。该公司的债务权益比为0.63，流动比率为1.50，速动比率为1.50。
Insider Activity
内幕活动
In related news, Director Jeffrey Bolton acquired 2,000 shares of Enhabit stock in a transaction on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the purchase, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Jeffrey Bolton acquired 2,000 shares of Enhabit stock in a transaction on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the purchase, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gregory S. Rush acquired 8,300 shares of Enhabit stock in a transaction on Monday, November 7th. The shares were bought at an average cost of $12.69 per share, with a total value of $105,327.00. Following the completion of the purchase, the director now owns 16,597 shares in the company, valued at $210,615.93. The disclosure for this purchase can be found here. In the last three months, insiders bought 13,000 shares of company stock valued at $164,903.
在相关新闻中，董事杰弗里·博尔顿在11月9日星期三的一次交易中收购了2,000股EnHabit股票。这只股票是以每股12.75美元的平均价格购买的，总价值为25,500.00美元。收购完成后，董事现在直接拥有该公司14,597股股份，价值186,111.75美元。此次收购是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过美国证券交易委员会网站。在相关新闻中，董事杰弗里·博尔顿在11月9日星期三的一次交易中收购了2,000股EnHabit股票。这只股票是以每股12.75美元的平均价格购买的，总价值为25,500.00美元。收购完成后，董事现在直接拥有该公司14,597股股份，价值186,111.75美元。此次收购是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过美国证券交易委员会网站。此外，在11月7日星期一的一次交易中，董事格雷戈里·S·拉什收购了8,300股EnHabit股票。这些股票的平均价格为每股12.69美元，总价值为105,327.00美元。收购完成后，董事现在拥有该公司16,597股票，价值210,615.93美元。关于这次购买的披露可以找到这里。在过去的三个月里，内部人士购买了1.3万股公司股票，价值164,903美元。
Hedge Funds Weigh In On Enhabit
对冲基金对EnHabit的看法
A number of large investors have recently modified their holdings of the business. BlackRock Inc. purchased a new position in shares of Enhabit during the 3rd quarter worth approximately $97,492,000. Vanguard Group Inc. purchased a new position in shares of Enhabit during the 3rd quarter worth approximately $77,886,000. State Street Corp purchased a new position in shares of Enhabit during the 3rd quarter worth approximately $22,827,000. Systematic Financial Management LP purchased a new position in shares of Enhabit during the 3rd quarter worth approximately $20,566,000. Finally, Dimensional Fund Advisors LP purchased a new position in shares of Enhabit during the 3rd quarter worth approximately $9,662,000. 95.55% of the stock is owned by hedge funds and other institutional investors.
一些大型投资者最近调整了对该公司的持股。贝莱德股份有限公司在第三季度购买了价值约97,492,000美元的宜居新股头寸。先锋集团在第三季度购买了价值约77,886,000美元的EnHabit新股票头寸。道富集团在第三季度购买了EnHabit的新头寸，价值约22,827,000美元。系统财务管理公司在第三季度购买了价值约20,566,000美元的EnHabit股票的新头寸。最后，Dimension Fund Advisors LP在第三季度购买了EnHabit的新头寸，价值约9,662,000美元。95.55%的股票由对冲基金和其他机构投资者持有。
Enhabit Company Profile
安居公司简介
(Get Rating)
(获取评级)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
EnHabit，Inc.在美国提供家庭健康和临终关怀服务。它的家庭健康服务包括患者教育、疼痛管理、伤口护理和换药、心脏康复、输液治疗、药物管理和熟练的观察和评估服务；治疗慢性疾病和状况的做法，包括糖尿病、高血压、关节炎、阿尔茨海默病、低视力、椎管狭窄、帕金森病、骨质疏松症、复杂伤口护理和慢性疼痛，以及针对糖尿病、充血性心力衰竭、骨科术后手术或损伤和呼吸系统疾病的特定疾病计划；以及物理、职业和语言治疗师提供治疗服务。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Is the Worst Behind for Under Armor Stock with a New CEO?
- Analysts Like The Fit Of Skechers USA
- What Does Microsoft's Investment in ChatGBT Mean for MSFT Stock?
- Can We Trust The Rally In The S&P 500
- Energy Surge: Four Oil-And-Gas Stocks Setting Up In Bullish Bases
- 免费获取StockNews.com关于EnHabit的研究报告(Ehab)
- Under Armor Stock的新任CEO是最糟糕的吗？
- 分析师喜欢斯凯奇美国公司的Fit
- 微软投资ChatGBT对微软股票意味着什么？
- 我们能相信标普500指数的涨势吗
- 能源飙升：四只石油和天然气类股看涨
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
接受《居住者日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对EnHabit和相关公司的最新新闻和分析师评级的每日简要摘要。